Search research articles
Contact Us
Filters
Showing results (31-40 of 113) with videos related to
Page
of 12
Sort By:
Cancer Research
|
December 16, 1998
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
N Keshelava, R C Seeger, S Groshen, et al.
Blood Cancer Journal
|
July 19, 2014
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
A Tagde, H Singh, M H Kang, et al.
Neurochemical Research
|
April 1, 1978
Isolation of human nerve growth factor from placental tissue
L D Goldstein, C P Reynolds, J R Perez-Polo
Diagnostic Cytopathology
|
January 1, 1991
Fine-needle aspiration cytology and the diagnosis of neoplasms in the pediatric age group
L J Layfield, B Glasgow, N Ostrzega, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads
R C Seeger, D D Vo, J Ugelstad, et al.
Cancer Research
|
June 30, 2001
N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase
H Wang, B J Maurer, C P Reynolds, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Multiple defects of the nerve growth factor receptor in human neuroblastomas
C Azar, N J Scavarda, C P Reynolds, et al.
Journal of Neural Transplantation & Plasticity
|
April 1, 1992
Transplantation of human neuroblastoma cells, catecholaminergic and non-catecholaminergic: effects on rotational behavior in Parkinson's rat model
J S Manaster, T Feuerman, C P Reynolds, et al.
Cancer Research
|
April 1, 1982
Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant
C P Reynolds, D A Reynolds, E P Frenkel, et al.
Leukemia
|
May 3, 2002
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
P H O'Donnell, W-X Guo, C P Reynolds, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 113) with videos related to
Sort By:
Page
of 12
Cancer Research
|
December 16, 1998
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
N Keshelava, R C Seeger, S Groshen, et al.
Blood Cancer Journal
|
July 19, 2014
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
A Tagde, H Singh, M H Kang, et al.
Neurochemical Research
|
April 1, 1978
Isolation of human nerve growth factor from placental tissue
L D Goldstein, C P Reynolds, J R Perez-Polo
Diagnostic Cytopathology
|
January 1, 1991
Fine-needle aspiration cytology and the diagnosis of neoplasms in the pediatric age group
L J Layfield, B Glasgow, N Ostrzega, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads
R C Seeger, D D Vo, J Ugelstad, et al.
Cancer Research
|
June 30, 2001
N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase
H Wang, B J Maurer, C P Reynolds, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Multiple defects of the nerve growth factor receptor in human neuroblastomas
C Azar, N J Scavarda, C P Reynolds, et al.
Journal of Neural Transplantation & Plasticity
|
April 1, 1992
Transplantation of human neuroblastoma cells, catecholaminergic and non-catecholaminergic: effects on rotational behavior in Parkinson's rat model
J S Manaster, T Feuerman, C P Reynolds, et al.
Cancer Research
|
April 1, 1982
Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant
C P Reynolds, D A Reynolds, E P Frenkel, et al.
Leukemia
|
May 3, 2002
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
P H O'Donnell, W-X Guo, C P Reynolds, et al.
Page
of 12